Provectus' media/communications profile has resulted in this blog being more closely associated with the company, PV-10 and their digital brand. Google "Provectus Pharmaceuticals" and the blog shows up in the top 10 search results returned. Most searches with Provectus + [another word related to oncology or dermatology] may well result in a list that includes one or more blog posts. Thus, tracking unique visitors to the blog, I think, might be a decent proxy for tracking awareness of the company.
At the blog's first anniversary, readership statistics were:
After only 6 months following that date (November 16) -- that is, November 17, 2012 to May 16, 2013 -- readership statistics like unique visitors are nearly the same. Blog readership over the last 6 months has nearly matched readership over the blog's first 12 months.
The point I wish to make here is that while the share price has lagged, awareness of Provectus and PV-10 (measured through unique visitors to this blog) has steadily grown.